A detailed history of Cibc Private Wealth Group, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 11 shares of GKOS stock, worth $1,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Previous 11 -0.0%
Holding current value
$1,572
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$89.48 - $118.35 $357 - $473
4 Added 57.14%
11 $1,000
Q1 2024

May 10, 2024

BUY
$76.4 - $96.33 $534 - $674
7 New
7 $0
Q3 2018

Nov 14, 2018

SELL
$38.13 - $68.37 $9,532 - $17,092
-250 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$27.62 - $44.51 $6,905 - $11,127
250 New
250 $10,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.8B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.